PAULA DE TOLEDO

Universidad Carlos III de Madrid

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (7)

Eduardo Anguita Mandly

Professor (Profesor Titular)

Universidad Complutense de Madrid

SPAIN

View details

ROSA MARIA AYALA DIAZ

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

José-Ángel Hernández-Rivas

SPAIN

View details

María C Ovejero-Benito

Profesora Colaboradora Doctora

Universidad CEU San Pablo

SPAIN

View details

Maria Linares

Assistant PhD Professor

Universidad Complutense de Madrid

SPAIN

View details

Javier Pascau

Full professor

Universidad Carlos III de Madrid Escuela Politécnica Superior

SPAIN

View details

Carolina Martínez-Laperche

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

PAULA DE TOLEDO

Research Interests

Explore related searches

Contact this professor

Articles (8)

Attention in surgical phase recognition for endoscopic pituitary surgery: Insights from real-world data

Correction to: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA (Scientific Reports, (2022), 12, 1, (13057), 10.1038/s41598-022-17271-3)

Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients (Frontiers in Immunology, (2023), 14, (1188818), 10.3389/fimmu.2023.1188818)

Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.

Extensive pharmacokinetic variability of Levetiracetam. ¿Are doctors aware?

Collaborators (7)

Eduardo Anguita Mandly

ROSA MARIA AYALA DIAZ

José-Ángel Hernández-Rivas

María C Ovejero-Benito

Maria Linares

Javier Pascau

Carolina Martínez-Laperche

Make your next move.